SOUTH MIAMI HOSPITAL
1. Target Overview & Investment Thesis
SOUTH MIAMI HOSPITAL is a 375-bed suburban community hospital in MIAMI-DADE, FL with $688.4M in net patient revenue and a 11.6% operating margin. The hospital serves a payer mix of 15.8% Medicare, 16.7% Medicaid, and 67.5% commercial.
Thesis: Platform Growth. Our ML models identify $50.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.6% to 19.0% (+736bps).
| Net Revenue HCRIS | $688.4M |
| Current EBITDA COMPUTED | $80.0M |
| Operating Margin COMPUTED | 11.6% |
| Occupancy HCRIS | 57.4% |
| Revenue / Bed COMPUTED | $1.8M |
| Net-to-Gross HCRIS | 26.6% |
| Distress Probability ML | 48.7% |
2. Market Context & Competitive Position
FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 11.6% places it above the state median. Among 96 size-comparable peers (188-750 beds), the median margin is 4.1%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (188-750), prioritizing same-state peers. 96 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SOUTH MIAMI HOSPITAL (Target) | FL | 375 | $688.4M | 11.6% |
| UNIVERSITY OF MIAMI HOSP & CLI | FL | 532 | $2.36B | 0.9% |
| MOFFITT CANCER CENTER | FL | 218 | $1.91B | 16.0% |
| LEE MEMORIAL HOSPITAL | FL | 748 | $1.28B | 17.4% |
| MAYO CLINIC FLORIDA | FL | 304 | $1.09B | 21.6% |
| ASCENSION SACRED HEART PENSACO | FL | 559 | $1.04B | -10.0% |
| MOUNT SINAI MEDICAL CENTER OF | FL | 481 | $904.2M | 12.2% |
| TALLAHASSEE MEMORIAL HOSPITAL | FL | 483 | $871.6M | -4.8% |
| SHANDS JACKSONVILLE MEDICAL CE | FL | 481 | $861.4M | -7.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $50.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $14.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $13.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $13.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $8.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $441K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $80.0M |
| + RCM Uplift | +$50.7M |
| Pro Forma EBITDA | $130.7M |
| Current Margin | 11.6% |
| Pro Forma Margin | 19.0% |
| WC Released (1x) | $26.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $123.1M | $1.03B | 8.40x | 53.1% |
| Base (11x exit) | 10.0x | 11.0x | $123.1M | $1.18B | 9.57x | 57.1% |
| Bull Case | 9.0x | 11.0x | $110.8M | $1.39B | 12.50x | 65.7% |
| Bull (12x exit) | 9.0x | 12.0x | $110.8M | $1.54B | 13.93x | 69.4% |
| Bear Case | 11.0x | 10.0x | $135.4M | $741.2M | 5.47x | 40.5% |
| Bear (11x exit) | 11.0x | 11.0x | $135.4M | $859.3M | 6.35x | 44.7% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 96 hospitals with 188-750 beds
- Same-state prioritization (n=97)
- Comp margins: P25=-4.7% / P50=4.1% / P75=19.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.